Literatur
Kellum JA, Prowle JR (2018) Paradigms of acute kidney injury in the intensive care setting. Nat Rev Nephrol 14(4):217–230
Rosner MH, Perazella MA (2017) Acute kidney injury in patients with cancer. N Engl J Med 377(5):500–501
Hoste EA et al (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41(8):1411–1423
Koyner JL et al (2020) The impact of biomarkers of acute kidney injury on individual patient care. Nephrol Dial Transplant 35(8):1295–1305
Nusshag C et al (2017) Issues of acute kidney injury staging and management in sepsis and critical illness: a narrative review. Int J Mol Sci 18(7):1387
Thomas ME et al (2015) The definition of acute kidney injury and its use in practice. Kidney Int 87(1):62–73
Saha M, McDaniel JK, Zheng XL (2017) Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics. J Thromb Haemost 15(10):1889–1900
Nusshag C et al (2019) Cell cycle biomarkers and soluble urokinase-type plasminogen activator receptor for the prediction of sepsis-induced acute kidney injury requiring renal replacement therapy: a prospective, exploratory study. Crit Care Med 47(12):e999–e1007
Wei C et al (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17(8):952–960
Backes Y et al (2012) Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review. Intensive Care Med 38(9):1418–1428
Alfano M et al (2015) Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes. Sci Rep 5:13647
Mondino A, Blasi F (2004) uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol 25(8):450–455
Dande RR et al (2017) Soluble urokinase receptor and the kidney response in diabetes mellitus. J Diabetes Res. https://doi.org/10.1155/2017/3232848
Hayek SS et al (2015) Soluble urokinase receptor and chronic kidney disease. N Engl J Med 373(20):1916–1925
Hayek SS et al (2020) Soluble urokinase receptor and acute kidney injury. N Engl J Med 382(5):416–426
Chawla LS et al (2017) Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol 13(4):241–257
Zewinger S et al (2018) Dickkopf‑3 (DKK3) in urine identifies patients with short-term risk of eGFR loss. J Am Soc Nephrol 29(11):2722–2733
Federico G et al (2016) Tubular Dickkopf‑3 promotes the development of renal atrophy and fibrosis. JCI Insight 1(1):e84916
Schunk SJ et al (2019) Association between urinary dickkopf‑3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study. Lancet 394(10197):488–496
Zarbock A et al (2016) Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 315(20):2190–2199
Gaudry S et al (2016) Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375(2):122–133
Barbar SD et al (2018) Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med 379(15):1431–1442
Klein SJ et al (2018) Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Intensive Care Med 44(3):323–336
Hoste E et al (2020) Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study. Intensive Care Med 46(5):943–953
Ronco C (2019) Acute kidney injury biomarkers: Are we ready for the biomarker curve? Cardiorenal Med 9(6):354–357
Jin K et al (2017) Intensive monitoring of urine output is associated with increased detection of acute kidney injury and improved outcomes. Chest 152(5):972–979
Kellum JA et al (2015) Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol 26(9):2231–2238
Garnier F et al (2020) Reversibility of acute kidney injury in medical ICU patients: predictability performance of urinary tissue inhibitor of metalloproteinase‑2 x insulin-like growth factor-binding protein 7 and renal resistive index. Crit Care Med 48(4):e277–e284
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
C. Nusshag, C.J. Reuß, M. Dietrich, A. Hecker, C. Jungk, D. Michalski, M.O. Fiedler, M. Bernhard, C. Beynon, M. A. Weigand und T. Brenner geben an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Nusshag, C., Reuß, C.J., Dietrich, M. et al. Fokus Nephrologie. Anaesthesist 70, 250–256 (2021). https://doi.org/10.1007/s00101-020-00856-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00101-020-00856-w